The New England journal of medicine 2016-03-03
Tumor Regression and Allograft Rejection after Administration of Anti-PD-1.
Related Questions
New answer by Medical Oncologist at Albert Einstein College of Medicine at Montefiore Medical Center (November 28, 2020)
This highly challenging question addresses a very important general issue in the context of a unique patient case. How far can we push the boundaries of using checkpoint inhib...